GRAIL stands at the forefront of cancer screening innovation. Leveraging next-generation DNA sequencing, population-scale clinical studies, and state-of-the-art machine learning to help detect multiple cancer types. Visit GRAIL.com or Galleri.com to learn about the Galleri® multi-cancer early detection test.